Comparative Effectiveness of Empagliflozin in the US

Clinical trial NCT03363464 · COMPLETED

Trial details

NCT number: NCT03363464
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2017-10-16
Primary completion: 2026-07-09
Enrollment: 230000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.